ERBB2 and triple-negative breast carcinoma: RAI14 was highly expressed in basal-like breast carcinoma [molecules expressed as ER (-)/PR (-)/HER-2 (-), equivalent to triple-negative breast cancer] than that in paracancerous tissue.